EFFECT OF AGE ON ANTINOCICEPTIVE EFFECTS OF ELEVATED PLUS-MAZE EXPOSURE

被引:0
|
作者
FRUSSAFILHO, R [1 ]
OTOBONI, JR [1 ]
GIANNOTTI, AD [1 ]
AMARAL, ACS [1 ]
CONCEICAO, IM [1 ]
机构
[1] FDN MUNICIPAL ENSINO SUPER MARILIA,BR-17500 MARILIA,SP,BRAZIL
关键词
ELEVATED PLUS-MAZE; NOCICEPTION; AGE; RAT;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
It has been suggested that anxiety may be a critical factor in certain forms of non-opioid environmental analgesia. Furthermore, age has been reported to increase the anxiety levels in rats as measured in the elevated plus-maze. In the present investigation 10 young (3 months), 10 middle-aged (14-16 months) and 10 old (28-30 months) male Wistar tats were tested by the tail withdrawal assay of nociception before (baseline), and at 0 (T1) and 10 (T2) min after a 5-min exposure to the elevated plus-maze apparatus. Only old rats presented an increase in tail withdrawal latencies after elevated plus-maze exposure, even though this effect was statistically significant only immediately after exposure to the apparatus (baseline = 2.5 +/- 0.3 s; T1 = 3.8 +/- 0.3 s; T2 = 3.3 +/- 0.4 s). The results indicate that exposure to the elevated plus-maze induces a rapidly reversed and age-dependent antinociception in rats. They are also consistent with the proposed greater sensitivity of old rats to anxiogenic effects of the plus-maze.
引用
收藏
页码:827 / 829
页数:3
相关论文
共 50 条
  • [21] Time-of-Day and Age Impact on Memory in Elevated Plus-Maze Test in Rats
    Morales-Delgado, Nicanor
    Popovic, Natalija
    De la Cruz-Sanchez, Ernesto
    Caballero Bleda, Maria
    Popovic, Miroljub
    FRONTIERS IN BEHAVIORAL NEUROSCIENCE, 2018, 12
  • [22] Prior exposure to the elevated plus-maze sensitizes mice to the acute behavioral effects of fluoxetine and phenelzine
    Holmes, A
    Rodgers, RJ
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 459 (2-3) : 221 - 230
  • [23] EFFECTS OF DIAZEPAM ON BEHAVIORAL AND ANTINOCICEPTIVE RESPONSES TO THE ELEVATED PLUS-MAZE IN MALE-MICE DEPEND UPON TREATMENT REGIMEN AND PRIOR MAZE EXPERIENCE
    RODGERS, RJ
    LEE, C
    SHEPHERD, JK
    PSYCHOPHARMACOLOGY, 1992, 106 (01) : 102 - 110
  • [24] ANXIOGENIC PROPERTIES OF COCAINE IN THE RAT EVALUATED WITH THE ELEVATED PLUS-MAZE
    ROGERIO, R
    TAKAHASHI, RN
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1992, 43 (02) : 631 - 633
  • [25] Effects of under- and overcrowding on exploratory behavior in the elevated plus-maze
    Botelho, S.
    Estanislau, C.
    Morato, S.
    BEHAVIOURAL PROCESSES, 2007, 74 (03) : 357 - 362
  • [26] DEXMEDETOMIDINE SYNERGISM WITH MIDAZOLAM IN THE ELEVATED PLUS-MAZE TEST IN RATS
    SALONEN, M
    ONAIVI, ES
    MAZE, M
    PSYCHOPHARMACOLOGY, 1992, 108 (1-2) : 229 - 234
  • [27] Anxiety conditioned to nicotine in the elevated plus-maze is time dependent
    Tucci, S
    Cheeta, S
    Genn, RF
    Seth, P
    File, SE
    BEHAVIOURAL PHARMACOLOGY, 2002, 13 (08): : 615 - 620
  • [28] SOME CRITICAL DETERMINANTS OF THE BEHAVIOR OF RATS IN THE ELEVATED PLUS-MAZE
    GRIEBEL, G
    MOREAU, JL
    JENCK, F
    MARTIN, JR
    MISSLIN, R
    BEHAVIOURAL PROCESSES, 1993, 29 (1-2) : 37 - 47
  • [29] The effects of histaminergic agents in the dorsal hippocampus of rats in the elevated plus-maze test of anxiety
    Zarrindast, Mohammad-Reza
    Torabi, Monirsadat
    Rostami, Parvin
    Fazli-Tabaei, Soheila
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2006, 85 (03) : 500 - 506
  • [30] VIGABATRIN HAS AN ANXIOLYTIC EFFECT IN THE ELEVATED PLUS-MAZE TEST OF ANXIETY
    SAYIN, U
    PURALI, N
    OZKAN, T
    ALTUG, T
    BUYUKDEVRIM, S
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1992, 43 (02) : 529 - 535